Steven G. Smith
AstraZeneca (United Kingdom) · 137 works · 4,841 citations · h-index 32
Top works
- Cyclosporine in severe childhood atopic dermatitis: A multicenter study
- Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
- Selective RET kinase inhibition for patients with RET-altered cancers
- The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia
- Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia
- Nodular prurigo responds to cyclosporin
- Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone‐dependent severe asthma
- Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study
- The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study
- Allergen-induced Increases in Sputum Levels of Group 2 Innate Lymphoid Cells in Subjects with Asthma
- The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps
- Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)
- Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma
- Controlled trial of nimodipine in amyotrophic lateral sclerosis
- Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count
- Proceedings of the Canadian society of allergy and clinical immunology annual scientific meeting 2015
- Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent
- Severe eosinophilic asthma with nasal polyposis: A phenotype for improved sinonasal and asthma outcomes with mepolizumab therapy
- Glucagon‐like peptide‐1 receptor expression on human eosinophils and its regulation of eosinophil activation
- The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti–IL-5 Biologic Therapy